By every measure, the drugs were no better than placebos, full data revealed on Saturday. Was it the fault of the design of the studies, or our very hypotheses about heart disease?
This post first appeared in The New York Times – Business. Read the original article.How Cardiologists’ High Hopes for Two Drugs Were Dashed
The New York Times – Business:

Leave a Reply